Emergency and Critical Care Management of Acute Ischaemic Stroke.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 17, doi. 10.1007/s40263-014-0210-2
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2015 AND VI 29 AND IP 1
Results: 7
1
2
Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 1, doi. 10.1007/s40263-014-0213-z
- By:
- Publication type:
- Article
3
Post-Injection Delirium/Sedation Syndrome in Patients Treated with Olanzapine Pamoate: Mechanism, Incidence, and Management.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 41, doi. 10.1007/s40263-014-0216-9
- By:
- Publication type:
- Article
4
The Impact of Medication on Health-Related Quality of Life in Patients with Generalized Anxiety Disorder.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 29, doi. 10.1007/s40263-014-0217-8
- By:
- Publication type:
- Article
5
Outpatient Pharmacotherapy and Modes of Administration for Acute Repetitive and Prolonged Seizures.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 55, doi. 10.1007/s40263-014-0219-6
- By:
- Publication type:
- Article
6
Medication Adherence in Patients with Parkinson's Disease.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 47, doi. 10.1007/s40263-014-0220-0
- By:
- Publication type:
- Article
7
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- CNS Drugs, 2015, v. 29, n. 1, p. 71, doi. 10.1007/s40263-014-0207-x
- By:
- Publication type:
- Article